After 30 years of laboratory work, a quick approval for STI571.

Journal of the National Cancer Institute ·Vol. 93 ·No. 13 ·2001-07-04 ·Pages 972

Arnold K

Abstract

暂无摘要

MeSH Terms

Antineoplastic Agents/therapeutic use Benzamides Clinical Trials as Topic Drug Industry Humans Imatinib Mesylate Leukemia, Myelogenous, Chronic, BCR-ABL Positive/drug therapy Piperazines/therapeutic use Pyrimidines/therapeutic use Time Factors United States United States Food and Drug Administration

Chemicals

Antineoplastic Agents Benzamides Piperazines Pyrimidines Imatinib Mesylate

Authors & Affiliations

1 authors, click to expand affiliations / ORCID

Arnold K

Article Info

Journal

Journal of the National Cancer Institute

Abbr.

J Natl Cancer Inst

ISSN

0027-8874

DOI

10.1093/jnci/93.13.972

Published

2001-07-04

Pages

972

Language

English

Region

United States

NLM ID

7503089

Subset

External Links

PubMed source DOI: 10.1093/jnci/93.13.972 View journal details

Analysis Services

After 30 years of laboratory work, a quick approval for STI571.

Contact

WeChat Official Account